| Literature DB >> 26247204 |
Jung Hee Koh1, Seung Min Jung1, Jennifer Jooha Lee1, Kwi Young Kang1, Seung-Ki Kwok1, Sung-Hwan Park1, Ji Hyeon Ju1.
Abstract
OBJECTIVE: The relationship between mechanical stress and radiographic progression in rheumatoid arthritis (RA) is unclear. The assumption is that mechanical stress is greater in the dominant hand. Therefore, the aim of the present study was to compare the presence and progression of erosions and joint space narrowing (JSN) in the dominant and non-dominant hand.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26247204 PMCID: PMC4527732 DOI: 10.1371/journal.pone.0135409
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Baseline characteristics of the 194 patients with newly-diagnosed rheumatoid arthritis.
| Parameters | N (%) |
|---|---|
| Age, years | 50.7 ± 1.0 |
| Female | 155 (79.9) |
| Dominant hand | |
| Right | 185 (95.4) |
| Left | 9 (4.6) |
| Documented hand synovitis during follow-up | 105 (54.1) |
| Smoking status at diagnosis | |
| Non-smoker | 165/182 (90.7) |
| Ex-smoker | 6/182 (3.3) |
| Current smoker | 11/182 (6.0) |
| Rheumatoid factor | 174.6 ± 15.4 |
| Anti-citrullinated peptide antibody | 160.6 ± 8.4 |
| Baseline erythrocyte sediment rate, mm/hr | 43.2 ± 2.2 |
| Baseline C-reactive protein | 1.3 ± 0.2 |
| Treatment | |
| Methotrexate use | 172 (88.7) |
| - Methotrexate dose, mg/week | 9.7 ± 0.3 |
| Use of other conventional DMARDs | 139 (71.6) |
| Glucocorticoid use | 147 (75.8) |
| Biologics | 27 (14.1) |
| Mean follow-up duration, years | ± 0.1 |
| - Patients without joint damage at baseline | 39.18) |
| - Joint damage progression during follow-up | 64 (32.99) |
DMARDs, disease-modifying anti-rheumatic drugs
a Plus-minus values represent the mean ± SE.
b Reference range, 0–20 IU/mL.
c Reference range, < 7 U/mL.
d Reference range, 0.01–0.47 IU/mL.
Fig 1Hand total, erosion and joint space narrowing (JSN) van der Heijde modified Sharp scores (HSS) at baseline and at 2-year follow-up, time-to-radiographic progression and annual progression according to handedness.
Radiographic progression was defined as a change in the erosive or JSN HSS ≥ 1.5 and a total HSS ≥ 3 in both hands during the follow-up period. (A) Baseline and follow-up total HSS were significantly higher in the dominant hand than in the non-dominant hand. The Log-rank test identified a significant difference in overall progression between the dominant and non-dominant hand (P = 0.041). (B and C) Baseline and follow-up erosion and JSN score were significantly higher in the dominant hand than in the non-dominant hand. The overall erosion and JSN progression rates were 5.7% and 7.5% respectively, during the 2-year follow period. (D) Annual progression of erosion, JSN, and both, were more rapid in the dominant hand.
Annual changes in the van der Heijde modified Sharp score between the dominant and non-dominant hand.
| Score | Non-Dominant | Dominant | p-value |
|---|---|---|---|
| Mean±SE | Mean±SE | ||
| Erosion + JSN | 0.65±0.10 | 1.23±0.16 | < 0.001 |
| Erosion | 0.20±0.03 | 0.38±0.07 | 0.011 |
| PIPs | 0.01±0.01 | 0.04±0.02 | 0.116 |
| MCPs | 0.01±0.01 | 0.05±0.02 | 0.072 |
| Wrist | 0.16±0.03 | 0.29±0.06 | 0.044 |
| JSN | 0.46±0.08 | 0.85±0.11 | < 0.001 |
| PIPs | 0.08±0.03 | 0.20±0.04 | < 0.001 |
| MCPs | 0.06±0.03 | 0.11±0.03 | 0.156 |
| Wrist | 0.31±0.06 | 0.54±0.09 | < 0.001 |
| Patients without initial radiographic joint damage | |||
| Erosion | 0.08±0.03 | 0.08±0.03 | >0.999 |
| JSN | 0.25±0.06 | 0.58±0.11 | <0.001 |
| Erosion+JSN | 0.33±0.06 | 0.67±0.12 | 0.002 |
| Patients with initial radiographic joint damage | |||
| Erosion | 0.27±0.05 | 0.57±0.11 | 0.008 |
| JSN | 0.59±0.13 | 1.02±0.17 | <0.001 |
| Erosion+JSN | 0.85±0.15 | 1.59±0.25 | <0.001 |
| Patients with normal CRP | |||
| Erosion | 0.16±0.04 | 0.15±0.04 | 0.657 |
| JSN | 0.35±0.12 | 0.62±0.10 | 0.005 |
| Erosion+JSN | 0.51±0.13 | 0.76±0.12 | 0.016 |
| Patients with elevated CRP | |||
| Erosion | 0.23±0.06 | 0.63±0.13 | <0.001 |
| JSN | 0.57±0.12 | 1.10±0.20 | <0.001 |
| Erosion+JSN | 0.80±0.14 | 1.74±0.30 | <0.001 |
JSN, joint space narrowing; MCPs, metacarpal joints; PIPs, proximal interphalangeal joints; SE, Standard error
Demographic and disease factors associated with the rate of annual progression in the dominant and non-dominant hand according to single GEE analysis.
| Variable | Erosion | JSN | Erosion + JSN | |||
|---|---|---|---|---|---|---|
| β coefficient | p-Value | β coefficient | p-Value | β coefficient | p-value | |
| Dominant hand | 0.18 | 0.004 | 0.39 | <0.001 | 0.58 | <0.001 |
| Abnormal ESR | 0.26 | <0.001 | 0.36 | 0.009 | 0.62 | <0.001 |
| Abnormal CRP | 0.28 | 0.002 | 0.35 | 0.035 | 0.63 | 0.005 |
| High-positive ACPA | 0.39 | 0.001 | 0.50 | 0.003 | ||
| Other cDMARDs | -0.50 | 0.012 | -0.58 | 0.047 | ||
| Steroid use | 0.23 | 0.002 | 0.50 | <0.001 | 0.73 | <0.001 |
| Baseline HSS | 0.08 | <0.001 | 0.05 | 0.028 | 0.08 | <0.001 |
ACPA, anti-citrullinated peptide antibodies; cDMARDs, conventional disease-modifying anti-rheumatic drugs; CRP, C-reactive protein; ESR, erythrocyte sediment rate; HSS, van der Heijde modified Sharp score; MTX, methotrexate; RF, rheumatoid factor; JSN, joint space narrowing
a Reference range, < 15 mm/hr.
b Reference range, 0.01–0.47 IU/mL.
c Reference range, < 7 U/mL. A high positive ACPA value > 21 U/mL (three times the upper normal limit).
Factors associated with the rate of annual progression in the dominant and non-dominant hand according to multivariate GEE analysis.
| Variable | Erosion | JSN | Erosion and JSN | |||
|---|---|---|---|---|---|---|
| β coefficient | p-Value | β coefficient | p-Value | β coefficient | p-value | |
| Dominant hand | 0.16 | 0.032 | 0.38 | 0.006 | 0.53 | 0.003 |
| Abnormal CRP | 0.25 | 0.001 | 0.29 | 0.044 | 0.52 | 0.006 |
| Baseline HSS | 0.07 | <0.001 | 0.05 | 0.033 | 0.08 | <0.001 |
| Other cDMARDs use | -0.51 | 0.002 | -0.59 | 0.010 | ||
cDMARDs, conventional disease-modifying anti-rheumatic drugs; CRP, C-reactive protein; HSS, van der Heijde modified Sharp score; JSN, joint space narrowing.
aReference range, 0.01–0.47 IU/mL
Comparison of the mean mid-bone-to-periarticular BMD ratio in the right and left hands.
| Right mid-bone-to-periarticular BMD ratio (IQR) | Left mid-bone-to-periarticular BMD ratio (IQR) | p-value | |
|---|---|---|---|
| 2nd PIP | 0.52 (0.43–0.63) | 0.51 (0.43–0.61) | 0.488 |
| 3rd PIP | 0.51 (0.45–0.61) | 0.53 (0.46–0.57) | 0.705 |
| 4th PIP | 0.49 (0.42–0.55) | 0.47 (0.42–0.54) | 0.664 |
| 5th PIP | 0.50 (0.45–0.61) | 0.49 (0.42–0.60) | 0.672 |
| mean | 0.51 (0.47–0.59) | 0.50 (0.45–0.56) | 0.538 |
BMD, bone mineral density; IQR, interquartile range; PIPs, proximal interphalangeal joints.